Companies

the BioMag and CoMag ballasted-biology systems and Memcor membranes treat mine and petrochemical water, using microscopic magnetite to accelerate settling of activated sludge.

Guayule Latex — Plant-derived.

Pioneers like Zhongkou Clean Energy are closing the loop by converting municipal biogas into Bio-CNG to fuel entire city bus fleets.

Stimplex® — Ascophyllum nodosum extract; distributed globally via BASF since 2024.

LG-1, Double Strength, Concentrate — Ecklonia maxima extract, Cold Micronisation Process, 170+ field trials.

the leading genealogy-focused DTC brand, running custom Illumina SNP arrays and CLIA-grade ancestry and cousin-matching at very large scale, with a redesigned 2026 user experience.

Europe's largest dairy cooperative pays farmers a premium for Bovaer-produced milk, monetising verified emission reductions through ESG certificates sold to corporate buyers. Arla reported expanded adoption across its member base in 2025–2026.

PF milk proteins, casein micelles — Downstream optimisation, R&D stage.

Biozyme Crop+, Biozyme Seed Plus — Seaweed + amino-acid complex via BILT lacto-fermentation.

Hawaii-based Blue Ocean Barns obtained FDA clearance for its Bromera Asparagopsis product, now used by Ben & Jerry's supply-chain dairies to reduce Scope 3 emissions.

Shanghai-based startup that received safety certification in 2025 and operates a 3,000 m² R&D centre with pilot fermenters for milk and egg protein expression, targeting the domestic confectionery industry.

a WGS-focused DTC leader offering 30x whole-genome sequencing at promotional pricing around EUR 169, returning raw data and customized reports to a global clientele under IVDR certification.

Accredited food, feed & veterinary testing — ISO 17025 network, EU AMR and zoonosis panels.

Rebyota (RBX2660) — First-in-world approved microbiota liquid enema.

the federal animal-health institute is the national reference lab for avian influenza, issuing the monthly Radar Bulletin and feeding the TSIS notification system.

Asparagopsis IP licence — CSIRO-originated global patent portfolio for seaweed-based mitigation.

the leading state R&D centre for avian influenza and African swine fever, operating BSL-3/ABSL-3 facilities to model cross-species transmission.

Open-sea cage mariculture — Indian pompano in 12 m cages, Andaman open-sea project.

National livestock disease informatics — Epidemiology, forecasting & forewarning of zoonoses.

a 3.81 billion USD (FY2024) veterinary diagnostics leader whose reference-lab network and VetConnect Plus software push PCR and antigen results into clinics; in May 2026 it expanded Fecal Dx to taeniid tapeworms including the zoonotic Echinococcus.

its InferRead AI performs sub-millimetre lung-nodule detection (below 5 mm nodules, ground-glass and vessel-convergence features) with individualized malignancy-probability scoring, deployed across Chinese hospitals along the patient pathway from screening to follow-up.

the market leader in submersible pens (SeaProtean), FlowFeeder waterborne feeding and acoustic fish tracking; in 2026 it grew and harvested greater amberjack in the Red Sea for NEOM's Topian.

A Lyon-based pioneer in high-diversity microbial ecosystems for oncology; lead drug MaaT013 reached pivotal phase 3 in Europe for acute graft-versus-host disease with an automated GMP plant.

MBT093 — Reference Genome Database for precise strain mapping.

Finnish-American startup building a commercial-scale production plant in the US after raising over $40M. Its recombinant egg-white positions itself as a hedge against avian-influenza-driven egg-price volatility.

a federated-learning AI company that, in a Nature Medicine report, trained deep-learning models on multi-hospital histopathology data without sharing patient slides, and pursues generalizable pathology, spatial transcriptomics and agentic AI co-pilots for researchers.

built the first AI pathology product cleared by the FDA (Paige Prostate), and in 2025 received FDA Breakthrough Device designation for Paige PanCancer Detect, an AI tool that flags suspicious cancer foci across multiple tissues and organs on a single AI-first digital-pathology platform.

its Path-IO (Pathology-driven Immunotherapy Optimization) multimodal platform combines pathomics, radiomics and clinical data to predict immunotherapy response in non-small-cell lung cancer, and its PathAI Discovery platform supports PD-L1 and stromal TIL biomarker development for clinical trials.

its Conson No. 1 intelligent aquaculture vessel farms salmon inside the hull and sails to cooler water, harvesting about 12 tons of Atlantic salmon on its first run.

in March 2026 expanded its digital-pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite (powered by AWS), integrating high-throughput scanners with LIS connectivity for hospital pathology departments across Western Europe.

Synthetic bromoform IVP — Pharmaceutically manufactured CHBr3 in oil/powder carriers, 95% reduction in trials.

operator of Ocean Farm 1, the world's first offshore fish farm, and the Smart Fish Farm concept for fully exposed open-ocean salmon production.

SeaFeed® (Asparagopsis) — Asparagopsis cultivation, distribution partnership with Orffa for EU market entry.

Seres Therapeutics' oral Firmicutes spore fraction, co-marketed with Nestle Health Science, was FDA-approved in April 2023 for recurrent CDI prevention — the first oral LBP, opening large-scale investment into the sector.

Europe's leading applied marine-engineering centre, validating numerical models of exposed-vessel and cage operations underpinning NS 9415.

Paris-based company specialising in yeast-expressed casein. Co-expression vectors enable simultaneous synthesis of all four casein types followed by calcium-ion-triggered micelle self-assembly. Partnered with Bel Group (Babybel, La Vache qui rit).

Microbial biostimulant consortia — Root-colonizing bacterial/fungal strains, 50+ country reach.

a clinical-grade DTC platform offering the TellmeGen Advanced panel (around EUR 149) and the Ultra 30x WGS test that analyzes the full genome for common and rare disease risk, with pharmacogenomic drug-response reporting under IVDR.

Every EggWhite (ovalbumin) — Pichia pastoris expression, GRAS, bakery and confectionery use.

Megafol® on the GEAPOWER® platform — Amino-acid/vitamin/betaine complex reprograms stress metabolism in 2–4 h.

Vedanta shifted from donor material to fully synthetic clonal consortia, commissioning a dedicated US GMP plant that produces defined-consortium drug VE303 directly from its own Master Cell Banks.

a leading Chinese consumer-genomics brand (listed among the 2026 top-10 DTC brands alongside 23Mofang and MeGene), integrating DNA reports into WeChat lifestyle apps for diet and fitness recommendations.

Shenzhen-based Xbiome uses deep learning for FMT donor matching and AI design of personalized multi-strain drugs for oncology patients (candidate XBI-302), running clinical trials in China and the US.

the pioneer of large methanol container ships; the 16,000-TEU Ane Maersk ran its maiden voyage on the AE7 Asia-Europe string in 2024, and Maersk has ordered eighteen large methanol-enabled vessels with a target of twenty-five in the fleet by 2030, aiming for net-zero GHG by 2040.

the Spectronaut DIA analysis software (the field's gold standard; Spectronaut 21 and SpectroMine 6 showcased at ASMS 2026), plus TrueDiscovery deep-proteome services on timsTOF.

the largest US renewable-natural-gas supplier; its Redeem RNG program captures dairy methane (the East Valley Cattle plant in Jerome, Idaho, its eighth dairy RNG facility, came online in June 2026), generating EPA RINs and California LCFS credits and feeding the bio-LNG pool for heavy-duty and marine transport.

the world's leading DAC operator (the Orca plant in Iceland removes ~4,000 t CO2/yr, scaling via Mammoth), partnering with biotech institutes on next-generation bio-functionalized sorbents that regenerate with heat-pump-grade energy (~50 C).

(SZSE 000930, Bengbu, Anhui; formerly BBCA Biochemical) produces citric acid at around 160,000 tonnes a year (with plants in Thailand and Jilin) by fermenting corn, and processes corn-cob residues into furfural and biochar.

hosts the AlphaFold Protein Structure Database with Google DeepMind, providing structure coverage for over 214 million protein sequences (open access); its DeepMind partnership was renewed and high-confidence heterodimer predictions were added in 2026.

high-throughput proteomics on the Orbitrap Astral, including quantitative host-cell-protein analysis of antibody therapeutics and target identification.

the Centaur Chemist platform; in 2020 it became the first company to advance an AI-designed drug (DSP-1181) into human clinical trials, and since November 2024 it has operated as part of Recursion.

immobilizes carbonic anhydrase on carriers (including magnetic nanoparticles and polymer hydrogels) for continuous wet CO2 capture and characterizes thermostable CA from extremophiles.

a fermentation conglomerate turning corn into xanthan gum, monosodium glutamate, glutamic acid and corn-gluten feed protein across subsidiaries in Shandong, Shaanxi, Inner Mongolia and Xinjiang.

the SPOTLIGHT platform integrating cryo-EM with machine-learning binding prediction; in June 2026 it partnered with Zymeworks to accelerate antibody drug discovery.

K3, Alpine detectors — direct-electron detection (high DQE).

the national sequencing centre uses nanopores for real-time ocean and soil metagenomic surveillance (e.g. nanoMDBG metagenome assembly).

a limestone CaO/CaCO3 mineralization loop accelerated by enzymatic humidification; it raised USD 150 million in 2026 and operates the first direct air capture facility in the United States.

its Yangtze fish and aquatic DNA barcode database covers 97% of Yangtze fish species; eDNA has revealed Chinese sturgeon spawning migration below the Gezhouba Dam and characterized pathogens in Yangtze finless-porpoise habitat, feeding the 2021-2030 fishing-ban mid-term assessment.

the Pharma.AI / Chemistry42 platform; its generative-AI-discovered TNIK inhibitor ISM001-055 (rentosertib) for idiopathic pulmonary fibrosis reported positive Phase IIa topline results (published in Nature Medicine) and is advancing toward pivotal trials — a flagship AI-designed asset.

metabolic engineering of microalgae with more efficient carbon-fixing enzymes (RuBisCO) for faster photosynthesis at low atmospheric CO2.